J M Ahearn|D T Fearon - JoVE Visualize

Showing results (141-150 of 154) with videos related to

Pageof 16

Sort By:

Molecular Immunology|October 6, 1999

Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP)A M Rosengard, L C Alonso, L C Korb, et al.

Medicine|September 1, 1985

Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsetsM C Hochberg, R E Boyd, J M Ahearn, et al.

Lupus|August 2, 2012

Complement fragment C3d is colocalized within the lipid rafts of T cells and promotes cytokine productionO Borschukova, Z Paz, I C Ghiran, et al.

Physiological Measurement|August 1, 2007

Experimental system for ex vivo measurement of murine aortic stiffnessL C Santelices, S J Calano, J C Erhart, et al.

Science (New York, N.Y.)|July 12, 1996

Mechanism of suppression of cell-mediated immunity by measles virusC L Karp, M Wysocka, L M Wahl, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993

A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrationsJ Dal Porto, T E Johansen, B Catipović, et al.

The Journal of Infectious Diseases|April 1, 1993

Human anti-endotoxin antibody HA-1A mediates complement-dependent binding of Escherichia coli J5 lipopolysaccharide to complement receptor type 1 of human erythrocytes and neutrophilsJ I Krieger, R C Fletcher, S A Siegel, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986

Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complementJ J Weis, D T Fearon, L B Klickstein, et al.

Transactions of the Association of American Physicians|January 1, 1990

Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardiumH F Weisman, T Bartow, M K Leppo, et al.

Immunity|March 1, 1996

Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigenJ M Ahearn, M B Fischer, D Croix, et al.

Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:

Pageof 16

Molecular Immunology|October 6, 1999

Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP)A M Rosengard, L C Alonso, L C Korb, et al.

Medicine|September 1, 1985

Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsetsM C Hochberg, R E Boyd, J M Ahearn, et al.

Lupus|August 2, 2012

Complement fragment C3d is colocalized within the lipid rafts of T cells and promotes cytokine productionO Borschukova, Z Paz, I C Ghiran, et al.

Physiological Measurement|August 1, 2007

Experimental system for ex vivo measurement of murine aortic stiffnessL C Santelices, S J Calano, J C Erhart, et al.

Science (New York, N.Y.)|July 12, 1996

Mechanism of suppression of cell-mediated immunity by measles virusC L Karp, M Wysocka, L M Wahl, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993

A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrationsJ Dal Porto, T E Johansen, B Catipović, et al.

The Journal of Infectious Diseases|April 1, 1993

Human anti-endotoxin antibody HA-1A mediates complement-dependent binding of Escherichia coli J5 lipopolysaccharide to complement receptor type 1 of human erythrocytes and neutrophilsJ I Krieger, R C Fletcher, S A Siegel, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986

Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complementJ J Weis, D T Fearon, L B Klickstein, et al.

Transactions of the Association of American Physicians|January 1, 1990

Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardiumH F Weisman, T Bartow, M K Leppo, et al.

Immunity|March 1, 1996

Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigenJ M Ahearn, M B Fischer, D Croix, et al.

Pageof 16